Drawing based on the label description. No photo yet.
“Free from physical defects.. Phentermine and topiramate extended-release capsules, 7.5 mg/46 mg are two-piece hard gelatin capsule with red opaque cap and white opaque body, filled with white to pale yellow pellets, imprinted in black ink with DRL on cap and 625 on body”
DRL 625 pill
Pill with imprint DRL 625 is red & white, capsule, 19 mm and has been identified as Phentermine and Topiramate Extended-Release 7.5 mg / 46 mg. It is supplied by Dr.reddys Laboratories Inc.
Controlled substance: Schedule IV
Phentermine and Topiramate Extended-Release 7.5 mg / 46 mg
- Imprint
- DRL 625
- Strength
- Phentermine 7.5 mg / Topiramate 46 mg
- Color
- Red, White
- Shape
- Capsule / oblong
- Size
- 19 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Dr.reddys Laboratories Inc
- Drug class
- Sympathomimetic amine anorectic
- NDC
- 43598-625, 43598-625-30
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
All Phentermine and Topiramate Extended-Release pills and guides
What is Phentermine and Topiramate Extended-Release used for?
Phentermine and Topiramate Extended-Release is a sympathomimetic amine anorectic.
- Medicine type
- Sympathomimetic amine anorectic
Official uses from the US prescribing label
Phentermine and topiramate extended-release capsules are indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in:
- Adult patients with obesity
- Adults with overweight in the presence of at least one weight-related comorbid condition
Limitations of Use
• The effect of phentermine and topiramate extended-release capsules on cardiovascular morbidity and mortality has not been established.
• The safety and effectiveness of phentermine and topiramate extended-release capsules in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
From the FDA-approved label on DailyMed (published May 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows DRL 625. The parts can be split between the two sides, so turn the pill over and check both.
- It is red & white, capsule, 19 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Phentermine Hydrochloride, Topiramate
Inactive: Cellulose, Microcrystalline, Fd&c Red No. 40, Fd&c Yellow No. 6, Ethylcellulose (10 Mpa.s), Gelatin, Hydroxypropyl Cellulose (90000 Wamw), Hypromellose 2208 (3 Mpa.s), Talc, Titanium Dioxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G443 G443
Dantrolene Sodium 100 mg
Red & yellow, capsule, 19 mm
Used for multiple sclerosis and muscle stiffness (spasticity)
-
LU E01
Rifampin 150 mg
Red, capsule, 18 mm
Used for tuberculosis (TB) and brucellosis
-
AA1
Methyltestosterone 10 mg
Red, capsule, 18 mm
Used for low testosterone and erectile dysfunction (ED)
Schedule III
-
435
Mesalamine 800 mg
Red, capsule, 19 mm
Used for ulcerative colitis and proctitis
-
AMNEAL 778
Budesonide 3 mg
Gray & red, capsule, 19 mm
Used for inflammatory bowel disease and year-round allergies
-
LU E02
Rifampin 300 mg
Red, capsule, 19 mm
Used for tuberculosis (TB) and brucellosis
Other Phentermine and Topiramate Extended-Release pills
- DRL 626 Phentermine and Topiramate Extended-Release 11.25 mg / 69 mg Green & white, capsule, 22 mm Schedule IV
- DRL 627 Phentermine and Topiramate Extended-Release 15 mg / 92 mg Orange & white, capsule, 23 mm Schedule IV
- DRL 624 Phentermine and Topiramate Extended-Release 3.75 mg / 23 mg White, capsule, 18 mm Schedule IV